Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-Trial); a randomized double blind placebo controlled multicenter study

Joepe J. Kaandorp*, Manon J.N.L. Benders, Carin M.A. Rademaker, Helen L. Torrance, Martijn A. Oudijk, Timo R. de Haan, Kitty W.M. Bloemenkamp, Monique Rijken, Maria G. van Pampus, Arie F. Bos, Martina M. Porath, Sidarto B. Oetomo, Christine Willekes, AW Danilo Gavilanes, Maurice G.A.J. Wouters, Ruurd M. van Elburg, Anjoke J.M. Huisjes, Saskia C.M.J.E.R. Bakker, Claudia A. van Meir, Jeannette von LindernJanine Boon, Inge P. de Boer, Robbert J.P. Rijnders, Corrie J.W.F.M. Jacobs, Cuno S.P.M. Uiterwaal, Ben Willem J. Mol, Gerard H.A. Visser, Frank van Bel, Jan B. Derks

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

65 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-Trial); a randomized double blind placebo controlled multicenter study'. Together they form a unique fingerprint.

Medicine & Life Sciences